Argentina In Vivo Cro Market Size & Outlook, 2023-2030

The in vivo cro market in Argentina is expected to reach a projected revenue of US$ 43.5 million by 2030. A compound annual growth rate of 5.9% is expected of Argentina in vivo cro market from 2024 to 2030.
Revenue, 2023 (US$M)
$29.2
Forecast, 2030 (US$M)
$43.5
CAGR, 2024 - 2030
5.9%
Report Coverage
Argentina

Argentina in vivo cro market highlights

  • The Argentina in vivo cro market generated a revenue of USD 29.2 million in 2023 and is expected to reach USD 43.5 million by 2030.
  • The Argentina market is expected to grow at a CAGR of 5.9% from 2024 to 2030.
  • In terms of segment, small molecule was the largest revenue generating modality type in 2023.
  • Large Molecule is the most lucrative modality type segment registering the fastest growth during the forecast period.


In vivo cro market data book summary

Market revenue in 2023USD 29.2 million
Market revenue in 2030USD 43.5 million
Growth rate5.9% (CAGR from 2023 to 2030)
Largest segmentSmall molecule
Fastest growing segmentLarge Molecule
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSmall Molecule, Large Molecule
Key market players worldwideIQVIA Holdings Inc, JSR Corp, Taconic Biosciences, Evotec SE, Janvier Labs, Charles River Laboratories International Inc, Icon PLC, Labcorp Holdings Inc, PAREXEL, GemPharmatech, PsychoGenics, Biocytogen, SMO-Group


Other key industry trends

  • In terms of revenue, Argentina accounted for 0.6% of the global in vivo cro market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil in vivo cro market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 146.0 million by 2030.

Small molecule was the largest segment with a revenue share of 63.7% in 2023. Horizon Databook has segmented the Argentina in vivo cro market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.


The Ministry of Health and the National Administration of Drugs, Food and Medical Devices (ANMAT) are making numerous efforts to increase clinical research & trial activities in Argentina. Moreover, ANMAT, in 2017, reduced the timelines for approval of clinical trials from 160 to 70 business days, modifying the Provision Nº 6677/10 that governs clinical research in Argentina. This is expected to propel the in vivo CRO market during the forecast period.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

In Vivo CRO Market Companies

Name Profile # Employees HQ Website

Argentina in vivo cro market size, by modality type, 2018-2030 (US$M)

Argentina In Vivo CRO Market Outlook Share, 2023 & 2030 (US$M)

Argentina in vivo cro market size, by modality type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more